Latest Breaking News On - Peter heerma - Page 1 : comparemela.com

Travere Therapeutics, Inc (NASDAQ:TVTX) Q1 2024 Earnings Call Transcript

Travere Therapeutics, Inc (NASDAQ:TVTX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesJula inrigMaury raycroftEric dubeyWilliam blairAnupam ramaAnne crotteauTyler van burenCarter gouldDeric dubeJoseph schwartzTim lugoChris clineJason zemanskyPeter heermaMirum pharmaceuticals

Brokerages Set Travere Therapeutics, Inc (NASDAQ:TVTX) Target Price at $17 85

Shares of Travere Therapeutics, Inc. (NASDAQ:TVTX – Get Free Report) have been assigned an average rating of “Moderate Buy” from the fifteen analysts that are presently covering the company, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold rating and nine have issued a buy rating on the company. The average […]

Peter heermaPiper sandlerChristopherr clineZurcher kantonalbank zurich cantonalbankWells fargo companyDynamic technology lab private ltdNisa investment advisorsSecurities exchange commissionTravere therapeutics company profileChina universal asset management coTravere therapeutics incTravere therapeuticsGet free reportExchange commissionInvestment advisorsUniversal asset management

Travere Therapeutics, Inc Expected to Earn FY2025 Earnings of ($1 80) Per Share (NASDAQ:TVTX)

Travere Therapeutics, Inc Expected to Earn FY2025 Earnings of ($1 80) Per Share (NASDAQ:TVTX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Christopherr clinePiper sandlerPeter heermaVanguard group incJacobs levy equity management incArmistice capitalWells fargo companyTravere therapeutics incTravere therapeuticsFree reportTravere therapeuticGet free reportWells fargoCapital managementLevy equity managementFinepoint capital

Travere Therapeutics, Inc (NASDAQ:TVTX) Forecasted to Post FY2028 Earnings of $4 29 Per Share

Travere Therapeutics, Inc. (NASDAQ:TVTX – Free Report) – Equities researchers at HC Wainwright cut their FY2028 earnings estimates for Travere Therapeutics in a report issued on Wednesday, April 24th. HC Wainwright analyst E. Arce now forecasts that the company will earn $4.29 per share for the year, down from their previous estimate of $4.66. HC […]

Ericm dubePeter heermaPiper sandlerTravere therapeutics incWells fargo companyVanguard group incHealthcare of ontario pension plan trust fundTravere therapeuticsFree reportTravere therapeuticGet free reportPartners managementCapital managementOntario pension plan trust fundVanguard groupIga nephropathy

HC Wainwright Boosts Travere Therapeutics (NASDAQ:TVTX) Price Target to $19 00

Travere Therapeutics (NASDAQ:TVTX – Get Free Report) had its price target lifted by HC Wainwright from $17.00 to $19.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s target price indicates a potential upside of 248.62% from the company’s […]

United statesPiper sandlerPeter heermaChristopherr clineRice hall james associatesWells fargo companyMirae asset global investments coTravere therapeutics company profileTravere therapeutics incSecurities exchange commissionTravere therapeuticsGet free reportTherapeutics stock downExchange commissionRetirement systemState retirement system